Search results for: 'pharma and biotech m a track 221b 221b'
- Did you mean
- pharma and biotech m a track 2016 2016
- Related search terms
- pharma and biotech m a trend 2020 2017
- pharma and biotech m a trends 2016 2024
- pharma biotech diagnostics 2024 2017
- pharma biotech diagnostics 2016 2024
- pharma biotech diagnostics 221b 2004
-
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the world's leading biopharma companies.
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 provides comprehensive understanding and unprecedented access to clinical stage partnering agreements entered into by the world's leading biopharma companies
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 report provides comprehensive understanding and unprecedented access to the preclinical stage partnering deals and agreements entered into by the worlds leading healthcare companies
Learn More -
Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2020-2024August 2024$3,995.00Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2020 to 2024
Learn More -
Global Biotech Partnering Terms and Agreements 2018-2023March 2023$3,995.00Global Biotech Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter biotech partnering deals.
Learn More -
Big Pharma Partnering Terms and Agreements 2020-2024October 2024$3,995.00Provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals
Learn More -
Diagnostic Collaboration and Licensing Deals 2020-2024November 2024$3,995.00Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2020 to 2024
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Infectious Diseases Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024September 2024$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More
